Phenobarbital, Serum or Plasma
Phenobarbital is a barbiturate that is most commonly used to control most types of seizures except for petit mal seizures. Like other antiepileptic drugs, it is a nervous system depressant; it has also been used as an antidepressant, and in some cases for treating insomnia. Phenobarbital is taken orally in either a pill form, or a liquid. It is metabolized by the liver and has a half-life between 50 and 120 hours depending on individual metabolism. Phenobarbital circulates through the body with roughly fifty percent bound to protein. Bioavailability for adults and children is greater than 90 percent, while neonates show only around 80 percent. Therapeutic range for Phenobarbital when used for treating epilepsy is 15 – 40 µg /mL, with toxic effects seen when serum levels are >60 µg /mL.
Phenobarbital stimulates the liver to activate liver enzymes, thus enhancing the metabolism of some other drugs. There are several drugs which affect Phenobarbital metabolism, including phenytoin (results in lower phenobarbital levels due to drug interaction) and valproic acid (results in higher phenobarbital levels due to inhibition of metabolism).
Ethanol (found in alcoholic beverages) stimulates liver enzymes, which enhances the metabolism of Phenobarbital, which then lessens the effectiveness of Phenobarbital and may cause adverse effects. As with other antiepileptic drugs, Phenobarbital has been shown to decrease the effectiveness of some oral contraceptives. In adults toxicity manifests central nervous system depression, which may include nystagmus (abnormal eye movement), ataxia (lack of muscle coordination), dysarthria (abnormal speech).
- Monitor patients receiving Phenobarbital therapy
- Aid in diagnosing/monitoring Phenobarbital overdose and prevention of Phenobarbital toxicity
Present in:
- Serum toxicity with Phenobarbital
- Patient taking Phenobarbital
Absent in:
- Patient not taking (but expected to take) Phenobarbital
| Clinical Status | mcg/mL | µmol/L |
| Therapeutic concentration | 15–40 | 65–172 |
| Toxic concentration (slowness, ataxia, nystagmus) | 35–80 | 151–345 |
| Coma with reflexes | 65–117 | 280–504 |
| Coma without reflexes | >100 | >431 |
Serum (Red top) preferred. Plasma EDTA (Lavender), Citrate (Light Blue) Plasma Heparin (Green).
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: 30 days
- Indian J Dermatol Venereol Leprol. 2011 Jan-Feb;77(1):7-15. PMID: 21220873
- Contraception. 2011 Jan;83(1):16-29. Epub 2010 Sep 15. PMID: 21134499
- Bishop ML, Duben-Engelkirk JL, Fody EP. Clinical Chemistry Principles, Procedures, Correlations. Philadelphia. Lippincott (1996).
- Lehmann CA. Saunders Manual of Clinical Laboratory Science. Philadelphia. W.B. Saunders Company (1998)
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757